Vion (formerly Oncorx) interesting play on Gene Therapy Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vion (formerly Oncorx) interesting play on Gene Therapy

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Louise Simpson who wrote (10)	7/16/1996 6:08:00 PM
From: Steve	of 370

I'm not certain of the reason for the low price/high volume in VION today other than the general market "correction." I know that VION has been busy with its recent private placement of convertible preferred shares. BTW, I purchased some more VIONW today. The company is on track with its development efforts. In a recent e-mail correspondence from Tom Klein, CFO of VION, he informs me that TAPET is at least 18 months from human clinicals. The company is looking into some technology which could speed that up, but he couldn't be specific. I still a believer, and the correction is an opportunity to pick up more. Steve

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next